Dr. Robert Bristow, MD of Princess Margaret Cancer Centre discusses molecular markers have greater impact on risk of recurrence than cancer stage and PSA levels at ASCO GU 2016
Advertisement
[the_ad id="32629"]
Molecular markers have greater impact on risk of recurrence than cancer stage and PSA levels
By Editor